Literature DB >> 17275554

Total thyroidectomy is the preferred treatment for patients with Graves' disease and a thyroid nodule.

Sarah Boostrom1, Melanie L Richards.   

Abstract

OBJECTIVE: To identify the indications and outcomes of total thyroidectomy for Graves' disease in a North American cohort. STUDY DESIGN AND
SETTING: Prospective database of 297 patients undergoing total thyroidectomy in a tertiary care center identified 49 patients with Graves'.
RESULTS: There were 37 women and 12 men (mean age, 37.9 years). Common indications for surgery were: refusal of radioactive iodine (20%), thyroid storm (18%), a thyroid nodule (16%), failure of I131(14%), and ophthalmopathy (14%). Complications included: symptomatic hypocalcemia (14%), permanent hypoparathyroidism (0%), and symptoms of recurrent laryngeal nerve injury (0%). Graves' patients had more bleeding (117 mL versus 48 mL, P<0.05). Clinical nodules were malignant in 38%. Papillary thyroid carcinoma occurred in 10% of patients, with 60% multifocal, and 60% lymph node metastases.
CONCLUSION: Total thyroidectomy for Graves' has minimal morbidity. Patients with Graves' and a thyroid nodule are at an increased risk for malignancy and should be treated with a total thyroidectomy.

Entities:  

Mesh:

Year:  2007        PMID: 17275554     DOI: 10.1016/j.otohns.2006.09.011

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  9 in total

1.  Risk factors for medically treated hypocalcemia after surgery for Graves' disease: a Swedish multicenter study of 1,157 patients.

Authors:  P Hallgrimsson; E Nordenström; M Almquist; A O J Bergenfelz
Journal:  World J Surg       Date:  2012-08       Impact factor: 3.352

2.  Single-incision transaxillary robotic total thyroidectomy for Graves' disease: improved feasibility and safety with novel robotic instrumentation.

Authors:  Balazs B Lörincz; Nikolaus Möckelmann; Rainald Knecht
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-08-21       Impact factor: 2.503

3.  Total thyroidectomy: a safe and effective treatment for Graves' disease.

Authors:  Jing Liu; Anna Bargren; Sarah Schaefer; Herbert Chen; Rebecca S Sippel
Journal:  J Surg Res       Date:  2011-01-26       Impact factor: 2.192

4.  The experience of gasless endoscopic-assisted thyroidectomy via the anterior chest approach for Graves' disease.

Authors:  Yun Hong; Shi-Tong Yu; Qian Cai; Fa-Ya Liang; Ping Han; Xiao-Ming Huang
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-10       Impact factor: 2.503

5.  Surgical management of pediatric Graves' disease: an effective definitive treatment.

Authors:  Elena Peroni; Maria Rachele Angiolini; Maria Cristina Vigone; Gilberto Mari; Giuseppe Chiumello; Edoardo Beretta; Giovanna Weber
Journal:  Pediatr Surg Int       Date:  2012-04-29       Impact factor: 1.827

6.  Safety and Feasibility of Robotic Transaxillary Thyroidectomy for Graves' Disease: A Retrospective Cohort Study.

Authors:  Mohammed Saad Bu Bshait; Jin Kyong Kim; Cho Rok Lee; Sang-Wook Kang; Jong Ju Jeong; Kee-Hyun Nam; Woong Youn Chung
Journal:  World J Surg       Date:  2022-01-11       Impact factor: 3.352

7.  Does thyroid surgery for Graves' disease improve health-related quality of life?

Authors:  Gregorio Scerrino; Giuditta Morfino; Nunzia Cinzia Paladino; Valentina Di Paola; Emanuele Amodio; Gaspare Gulotta; Sebastiano Bonventre
Journal:  Surg Today       Date:  2012-12-11       Impact factor: 2.549

8.  Papillary thyroid carcinoma and inflammation.

Authors:  Laura Fugazzola; Carla Colombo; Michela Perrino; Marina Muzza
Journal:  Front Endocrinol (Lausanne)       Date:  2011-12-16       Impact factor: 5.555

9.  Total thyroidectomy as a method of choice in the treatment of Graves' disease - analysis of 1432 patients.

Authors:  Toplica Bojic; Ivan Paunovic; Aleksandar Diklic; Vladan Zivaljevic; Goran Zoric; Nevena Kalezic; Vera Sabljak; Nikola Slijepcevic; Katarina Tausanovic; Nebojsa Djordjevic; Dragana Budjevac; Lidija Djordjevic; Aleksandar Karanikolic
Journal:  BMC Surg       Date:  2015-04-09       Impact factor: 2.102

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.